Click Here to return To Results

 

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study Lancet 370:389-397, Kappos,L.,et al, 2007 See this aricle in Pubmed Article Abstract Our data suggest that early initiation of treatment with interferon beta-1b prevents the development of confirmed disability, supporting its use after the first manifestation of relapsing-remitting MS.

Related Tags

(click to filter results - removes previous filter) BENEFIT study disability,neurological interferon interferon beta 1-b MRI,abnormal multiple sclerosis multiple sclerosis,monosymptomatic multiple sclerosis,relapsing multiple sclerosis,treatment of multiple sclerosis,treatment of,first attack treatment of neurologic disorder

Click Here to return To Results